NGC Update Service: August 10, 2015

Agency for Healthcare Research and Quality (AHRQ) sent this bulletin at 08/10/2015 01:45 PM EDT

National Guideline Clearinghouse (NGC)

August 10, 2015

New This Week

Guideline Summaries

American College of Radiology

ACR Appropriateness Criteria® assessment of gravid cervix. This updates a previously published guideline summary.
ACR Appropriateness Criteria® blunt chest trauma — suspected aortic injury. This updates a previously published guideline summary.
ACR Appropriateness Criteria® hematuria. This updates a previously published guideline summary.
ACR Appropriateness Criteria® infertility.
ACR Appropriateness Criteria® recurrent lower urinary tract infections in women. This updates a previously published guideline summary.
ACR Appropriateness Criteria® upper extremity swelling. This updates a previously published guideline summary.

Withdrawn Summaries

The withdrawn summaries listed below have been withdrawn from the NGC Web site because they no longer meet the NGC Inclusion Criteria. See the Guideline Archive for a complete list of guidelines that have been withdrawn from the NGC Web site.

European Association of Urology

Catheter-associated UTIs. In: Guidelines on urological infections.
Chronic pelvic pain. In: Guidelines on chronic pelvic pain.
Epididymitis and orchitis. In: Guidelines on urological infections.
Fournier's gangrene. In: Guidelines on urological infections.
Gastrointestinal aspects of chronic pelvic pain. In: Guidelines on chronic pelvic pain.
General treatment of chronic pelvic pain. In: Guidelines on chronic pelvic pain.
Guidelines on male hypogonadism.
Guidelines on penile curvature.
Gynaecological aspects of chronic pelvic pain. In: Guidelines on chronic pelvic pain.
Pelvic floor function and chronic pelvic pain. In: Guidelines on chronic pelvic pain.
Perioperative antibacterial prophylaxis in urology. In: Guidelines on urological infections.
Peripheral nerve pain syndromes. In: Guidelines on chronic pelvic pain.
Psychological aspects of chronic pelvic pain. In: Guidelines on chronic pelvic pain.
Sexological aspects of chronic pelvic pain. In: Guidelines on chronic pelvic pain.
Urethritis. In: Guidelines on urological infections.
Urological aspects of chronic pelvic pain. In: Guidelines on chronic pelvic pain.

Announcements

Conference News

The Guidelines International Network (G-I-N) 12th annual conference will take place from October 7–10, 2015 in Amsterdam. The theme is "Engaging all stakeholders. Guidelines from a societal perspective." To register and book a pre-conference course, visit the G-I-N Conference Web site.
Registration is now open for the Agency for Healthcare Research and Quality (AHRQ) 2015 Research Conference. It will be held October 4–6 at the Crystal Gateway Marriott Hotel and Convention Center in Crystal City, VA. The conference is titled "Producing Evidence and Engaging Partners to Improve Health Care." Visit the conference home page for more information.
The Guidelines International Network North America (G-I-N NA) continues to sponsor a monthly webinar series on topics of interest to the North American guideline community. Information on upcoming webinars, as well as audio files and slides from past webinars, is available on the G-I-N Web site.

U.S. Food and Drug Administration (FDA) Advisories

July 27, 2015: Gadolinium-based Contrast Agents for Magnetic Resonance Imaging (MRI): Drug Safety Communication - FDA Evaluating the Risk of Brain Deposits With Repeated Use: FDA is investigating the risk of brain deposits following repeated use of gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI). Recent publications in the medical literature have reported that deposits of GBCAs remain in the brains of some patients who undergo four or more contrast MRI scans, long after the last administration. It is unknown whether these gadolinium deposits are harmful or can lead to adverse health effects.
August 4, 2015: Proglycem (diazoxide): Gilenya (fingolimod): Drug Safety Communication - FDA Warns About Cases of Rare Brain Infection: FDA is warning that a case of definite progressive multifocal leukoencephalopathy (PML) and a case of probable PML have been reported in patients taking Gilenya (fingolimod) for multiple sclerosis (MS). These are the first cases of PML reported in patients taking Gilenya who had not been previously treated with an immunosuppressant drug for MS or any other medical condition. As a result, information about these recent cases is being added to the drug label.
August 5, 2015: Implantable Left Ventricular Assist Devices (LVADs): FDA Safety Communication - Serious Adverse Events: FDA is alerting health care providers, patients, and caregivers about serious adverse events associated with LVADs. These adverse events include an increased rate of pump thrombosis (blood clots inside the pump) with Thoratec's HeartMate II and a high rate of stroke with the HeartWare HVAD since approval of the devices. FDA is also aware of bleeding complications related to both the Thoratec HeartMate II and HeartWare HVAD.

Health Awareness Topics - August 2015

National Breastfeeding Month (see related guidelines)
National Immunization Awareness Month (see related guidelines)
Psoriasis Awareness Month (see related guidelines)

How to Participate

Submit Guidelines: Visit our Submit Guidelines page for information on how to submit your organization's guidelines.
Suggest a Guideline for Possible Inclusion: Submit your suggestions for evidence-based clinical practice guidelines that you would like to see included in NGC.
Suggest a Guideline Synthesis Topic: We welcome your suggestions for guideline synthesis topics!

NGC's Sister Resource

Look for Quality Measures in AHRQ's National Quality Measures Clearinghouse (NQMC).

How satisfied are you with this e-mail bulletin? Give Us Your Feedback

Subscriber Services:
Change Your Profile | Unsubscribe | Help

Stay Connected:
Contact Us | Social Media